This case study demonstrates the application of an STZ-induced diabetic wound healing mouse model for evaluating the preclinical efficacy of a therapeutic intervention in diabetic wound repair research.
The study provides insights into diabetic wound model development, experimental workflow, and quantitative wound healing assessment strategies, highlighting key approaches for evaluating candidate therapies in a clinically relevant disease context.
What You Will Learn from This Case Study
By downloading this case study, you will gain insights into our capabilities in developing and evaluating STZ-induced diabetic wound healing models, including:
Complete the form to access this case study and explore Ace Therapeutics’ capabilities in STZ-induced diabetic wound healing models, silicone ring splint wound models, and preclinical efficacy evaluation.
Interested in developing a customized diabetic wound healing study? Contact our scientific team to discuss your research requirements.
Learn how the STZ-induced diabetes model can drive breakthroughs in client's diabetes research.
This case study demonstrates how our DIO mouse model supports clients in the preclinical efficacy evaluation of antidiabetic drugs.
Our case study details a surgical-chemical DN model in CD1 mice (UNx + low-dose STZ).
Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.
